Panacea Life Sciences Holdings, Inc. Unrealized Gain (Loss) on Derivatives
Panacea Life Sciences Holdings, Inc. (PLSH) reported Unrealized Gain (Loss) on Derivatives of -$828.69 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2019-03-29
- Panacea Life Sciences Holdings, Inc. unrealized gain (loss) on derivatives for fiscal 2018 was -$828.69K.
- Panacea Life Sciences Holdings, Inc. unrealized gain (loss) on derivatives for fiscal 2017 was -$667.20K.
- Panacea Life Sciences Holdings, Inc. unrealized gain (loss) on derivatives for fiscal 2016 was $0.00.
| Period end | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|
| 2018-12-31 | -$828.69K 10-K · filed 2019-03-29 |
| 2017-12-31 | -$667.20K 10-K · filed 2019-03-29 |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 |